Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
11%
OVERLAP
BY WEIGHT
51
# OF OVERLAPPING
HOLDINGS
VHT
422
HOLDINGS
13%
ALSO IN XPH
XPH
59
HOLDINGS
86%
ALSO IN VHT
SECTOR DRIFT (VHT minus XPH)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in VHT |
Weight in XPH |
Overlap | |
|---|---|---|---|---|
 |
MERCK & CO. INC. | 5.1% | 1.8% | 1.8% |
|
BRISTOL-MYERS SQUIBB CO | 1.9% | 1.7% | 1.7% |
|
JOHNSON & JOHNSON | 8.7% | 1.6% | 1.6% |
|
ELI LILLY & CO | 13.6% | 1.6% | 1.6% |
|
PFIZER INC | 2.2% | 1.5% | 1.5% |
VHT Overweight Relative to XPH
|
ELI LILLY & CO | 12.1% |
|
JOHNSON & JOHNSON | 7.1% |
|
ABBVIE INC | 6.3% |
|
UNITEDHEALTH GROUP INC | 4.8% |
|
MERCK & CO. INC. | 3.3% |
|
AMGEN INC | 3.2% |
|
THERMO FISHER SCIENTIFIC INC | 3.2% |
|
ABBOTT LABORATORIES | 2.7% |
|
GILEAD SCIENCES INC | 2.5% |
|
DANAHER CORP | 1.9% |
VHT Underweight Relative to XPH
|
AMYLYX PHARMACEUTICALS, INC. | -4.0% |
|
CRINETICS PHARMACEUTICALS INC | -3.4% |
|
MBX BIOSCIENCES INC | -3.0% |
|
DEFINIUM THERAPEUTICS INC | -2.7% |
|
OMEROS CORP | -2.7% |
|
ENLIVEN THERAPEUTICS, INC. | -2.2% |
|
ETON PHARMACEUTICALS, INC. | -2.1% |
|
NUVATION BIO INC CLASS A | -2.1% |
|
CORCEPT THERAPEUTICS INC | -2.1% |
|
TREVI THERAPEUTICS, INC. | -1.9% |